IMP3 and metastatic malignant neoplasm in the lymph nodes: The results showed that IMP3 expression was significantly associated with tumor size, differentiation, lymph node metastasis and the clinical stage of NSCLC (P=0.013, P<0.001, P=0.004 and P<0.001, respectively).